Answers are grounded in this paper and cite their sources.
Net-zero mitigation is expected to improve human health through air-quality co-benefits, but these benefits may be constrained by climate-driven warming, particularly in small greenhouse gas-emitting economies. Using Taiwan as a case study, this study applied an integrated LEAP-CMAQ-CRF framework to link net-zero energy pathways, air-quality responses, and mortality impact assessment. A 2×2 scenario design was used to separate mitigation co-benefits from climate penalties under present-day and +2°C warming conditions. Under present-day meteorology, net-zero mitigation reduced population-weighted PM2.5 (-35.7%) but increased MDA8 O3 (+18.8%). Under the combined warming and net-zero scenario relative to the baseline, PM2.5 remained substantially reduced (-35.0%), while O3 increased (+21.6%). Mortality decomposition further showed that +2°C warming added 97 PM2.5-related deaths (+0.3%) and 220 O3-related deaths (+0.6%), whereas net-zero mitigation reduced PM2.5-related deaths by 2,626 (-7.0%) but added 2,062 O3-related deaths (+5.5%). The final combined scenario reached 37,047 premature deaths, equivalent to 99.3% of the baseline level. Spatially, PM2.5 reductions were widespread, while O3 increases were concentrated mainly along western Taiwan and overlapped with several medium-high and high-SVI counties. These findings indicate that net-zero mitigation can reduce aggregate mortality risks, but its benefits are not pollutant-neutral or spatially uniform. Health-oriented integrated assessment should therefore evaluate both total risk reduction and residual burden redistribution across pollutants, climate conditions, and vulnerable regions.
No takes yet. Share an insight, caveat, or question.
Kuo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: